Geron reported earnings per share of -10 cents. This met the analyst estimate for EPS of -10 cents. The company reported revenue of $882,000. This was 215% better than the analyst estimate for ...

Reports Q4 revenue $47.54M, consensus $45.29M. “2024 was a terrific year for Geron (GERN) and for RYTELO, our first-in-class telomerase inhibitor, which we believe represents a highly ...

Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Leerink Partnrs dropped their Q4 2025 EPS estimates for shares of Geron in a note issued to investors on Wednesday, February 26th.

Geron Corporation earnings at a glance (GAAP) : -Earnings: -$25.35 Mln. vs. -$51.97 Mln. last year. -EPS: -$0.04 vs. -$0.09 last year. -Revenue: $47.54 Mln vs. $0.02 Mln last year. The views and ...

Geron (NASDAQ:GERN) Corporation reported its fourth-quarter 2024 earnings, missing analyst expectations with an EPS of -$0.04 against a forecast of -$0.03. The company also reported a significant ...